Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Audra L Stinchcomb

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Pharmaceutical Research|September 2, 2003
Xenobiotic bioconversion in human epidermis modelsAudra L Stinchcomb
Journal of Pharmaceutical Sciences|December 18, 2009
The role of entrepreneurial activities in academic pharmaceutical science researchAudra L Stinchcomb
Pharmaceutical Research|June 26, 2010
Vehicle composition influence on the microneedle-enhanced transdermal flux of naltrexone hydrochlorideMikolaj Milewski, Audra L Stinchcomb
Molecular Pharmaceutics|June 19, 2012
Estimation of maximum transdermal flux of nonionized xenobiotics from basic physicochemical determinantsMikolaj Milewski, Audra L Stinchcomb
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 6, 2004
Liquid chromatographic-mass spectrometric quantitation of Delta9-tetrahydrocannabinol and two metabolites in pharmacokinetic study plasma samplesSatyanarayana Valiveti, Audra L Stinchcomb
International Journal of Pharmaceutics|July 9, 2002
In vitro experiment optimization for measuring tetrahydrocannabinol skin permeationPrasad V N Challapalli, Audra L Stinchcomb
Journal of Pharmaceutical Sciences|May 26, 2012
Naltrexone salt selection for enhanced transdermal permeation through microneedle-treated skinMikolaj Milewski, Raghotham R Pinninti, Audra L Stinchcomb
Molecular Pharmaceutics|April 18, 2013
Effect of formulation pH on transport of naltrexone species and pore closure in microneedle-enhanced transdermal drug deliveryPriyanka Ghosh, Nicole K Brogden, Audra L Stinchcomb
Expert Opinion on Drug Delivery|March 9, 2010
Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skinMikolaj Milewski, Nicole K Brogden, Audra L Stinchcomb
Journal of Pharmaceutical Sciences|January 8, 2014
Fluvastatin as a micropore lifetime enhancer for sustained delivery across microneedle-treated skinPriyanka Ghosh, Nicole K Brogden, Audra L Stinchcomb
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Pharmaceutical Research|September 2, 2003
Xenobiotic bioconversion in human epidermis modelsAudra L Stinchcomb
Journal of Pharmaceutical Sciences|December 18, 2009
The role of entrepreneurial activities in academic pharmaceutical science researchAudra L Stinchcomb
Pharmaceutical Research|June 26, 2010
Vehicle composition influence on the microneedle-enhanced transdermal flux of naltrexone hydrochlorideMikolaj Milewski, Audra L Stinchcomb
Molecular Pharmaceutics|June 19, 2012
Estimation of maximum transdermal flux of nonionized xenobiotics from basic physicochemical determinantsMikolaj Milewski, Audra L Stinchcomb
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 6, 2004
Liquid chromatographic-mass spectrometric quantitation of Delta9-tetrahydrocannabinol and two metabolites in pharmacokinetic study plasma samplesSatyanarayana Valiveti, Audra L Stinchcomb
International Journal of Pharmaceutics|July 9, 2002
In vitro experiment optimization for measuring tetrahydrocannabinol skin permeationPrasad V N Challapalli, Audra L Stinchcomb
Journal of Pharmaceutical Sciences|May 26, 2012
Naltrexone salt selection for enhanced transdermal permeation through microneedle-treated skinMikolaj Milewski, Raghotham R Pinninti, Audra L Stinchcomb
Molecular Pharmaceutics|April 18, 2013
Effect of formulation pH on transport of naltrexone species and pore closure in microneedle-enhanced transdermal drug deliveryPriyanka Ghosh, Nicole K Brogden, Audra L Stinchcomb
Expert Opinion on Drug Delivery|March 9, 2010
Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skinMikolaj Milewski, Nicole K Brogden, Audra L Stinchcomb
Journal of Pharmaceutical Sciences|January 8, 2014
Fluvastatin as a micropore lifetime enhancer for sustained delivery across microneedle-treated skinPriyanka Ghosh, Nicole K Brogden, Audra L Stinchcomb
Pageof 8